Literature DB >> 21109154

Evidence-based guidelines for the management of brain metastases.

Sandeep S Bhangoo1, Mark E Linskey, Steven N Kalkanis.   

Abstract

The objective of this article is to present a concise summary of the most recent evidence-based guidelines in the management of metastatic brain tumors developed by the American Association of Neurologic Surgeons (AANS), Congress of Neurologic Surgeons (CNS), and the AANS/CNS Joint Section on Tumors in 2010. Target populations include patients with newly diagnosed metastases as well as recurrent or progressive lesions. The roles of radiotherapy, surgical resection, and stereotactic radiosurgery along with combination therapies are reviewed. Other topics include the role of chemotherapy, anticonvulsants, steroids, and investigational therapies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21109154     DOI: 10.1016/j.nec.2010.09.001

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  24 in total

Review 1.  The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Seung Chai Jung; Kyung Won Kim; Junhee Pyo
Journal:  J Neurooncol       Date:  2016-06-20       Impact factor: 4.130

Review 2.  Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Martin Kocher; Andrea Wittig; Marc Dieter Piroth; Harald Treuer; Heinrich Seegenschmiedt; Maximilian Ruge; Anca-Ligia Grosu; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-04-09       Impact factor: 3.621

3.  Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Authors:  Marcel A Kamp; Igor Fischer; Maxine Dibué-Adjei; Christopher Munoz-Bendix; Jan-Frederick Cornelius; Hans-Jakob Steiger; Philipp J Slotty; Bernd Turowski; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2017-12-20       Impact factor: 3.042

4.  Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.

Authors:  Federico Pessina; Pierina Navarria; Luca Cozzi; Stefano Tomatis; Anna M Ascolese; Ciro Franzese; Luca Toschi; Armando Santoro; Fiorenza De Rose; Davide Franceschini; Lorenzo Bello; Marta Scorsetti
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

5.  Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?

Authors:  Tony J C Wang; Shumaila Saad; Yasir H Qureshi; Ashish Jani; Tavish Nanda; Andrew M Yaeh; Tzlil Rozenblat; Michael B Sisti; Jeffrey N Bruce; Guy M McKhann; Jeraldine Lesser; Balazs Halmos; Mark B Stoopler; Andrew B Lassman; Simon K Cheng; Steven R Isaacson
Journal:  Neuro Oncol       Date:  2015-04-24       Impact factor: 12.300

6.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

7.  Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases.

Authors:  Kimberley S Mak; Justin F Gainor; Andrzej Niemierko; Kevin S Oh; Henning Willers; Noah C Choi; Jay S Loeffler; Lecia V Sequist; Alice T Shaw; Helen A Shih
Journal:  Neuro Oncol       Date:  2014-07-22       Impact factor: 12.300

8.  Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

Authors:  Daniel H Kim; Timothy E Schultheiss; Eric H Radany; Behnam Badie; Richard D Pezner
Journal:  J Neurooncol       Date:  2013-06-28       Impact factor: 4.130

Review 9.  Updates in the management of brain metastases.

Authors:  Nils D Arvold; Eudocia Q Lee; Minesh P Mehta; Kim Margolin; Brian M Alexander; Nancy U Lin; Carey K Anders; Riccardo Soffietti; D Ross Camidge; Michael A Vogelbaum; Ian F Dunn; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2016-08       Impact factor: 12.300

10.  Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases.

Authors:  Carsten Nieder; Kirsten Marienhagen; Astrid Dalhaug; Gro Aandahl; Ellinor Haukland; Adam Pawinski
Journal:  Med Oncol       Date:  2014-03-20       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.